logo

EMAGEON IN(NSDQ:EMAG)
Emageon''s Intelligent Visual Medical System is an enterprise- level advanced visualization and infrastructure solution that allows physicians and healthcare professionals to manage, access and visualize medical content using relevant multi-specialty tools through a dynamic user interface. Delivered through Emageon''s Enterprise Platform, hospital networks, clinics and imaging facilities are able to deploy a functionally rich, standards-based technology that permits faster access to future innovation while helping to lower the total cost of ownership.
# Employees: 356
Address: 1200 Corporate Drive Suite 200,Birmingham,AL,USA
Phone: 205-980-9222
Fax: 205-980-9815
Website: www.emageon.com
Email: info@emageon.com.
Sector: Medical
Industry: MEDICAL INFO SYS
Executive Officers
Charles A. Jett Jr. (Chmn.; Presi.; C.E.O.)
Douglas D. French (Dir.)
Randall W. Pittman (C.F.O.; Treas.)
Arthur P. Beattie (Dir.)
Roddy J.h. Clark (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2008
Next Earnings Date(Expected): 5/11/2009
Mean EPS (Next Qtr): ($0.15)
Mean EPS (Year): ($0.34)
Mean Estimate(Long Term): $30.00
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 4
Shares Performance
Period EMAG Compare to S&P
YTD -1.62 % 8.31 %
4 Weeks 3.41 % -9.75 %
12 Weeks -9.00 % 6.61 %
Shares Information
Analyst Coverage: Y
Avg Volume: 164095
Shares Outstanding: 21M
Market Cap: $0.04B
52 Week High: $2.80
52 Week Low: $0.75
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 EMAG split by factor of 0.200
Earnings Performance
EPS Growth in Last Quarter: -20.00 %
EPS Growth in Last Year: -166.67 %
Sales Growth in Last Quarter: 0.38 %
Sales Growth in Last Quarter: -43.93 %
Financials
Qtr Book Value: $1.66
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 0.560
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia